and Robert E. Schmidt2
(1)
Sunnybrook and St Michael’s Hospitals, University of Toronto, Toronto, ON, Canada
(2)
Division of Neuropathology Department of Pathology, Washington University School of Medicine, St. Louis, MO, USA
A brief discussion of some of the clinical issues involved in the diagnosis of peripheral neuropathy will be helpful to pathologists who receive clinical data from their neurological colleagues and wish to correlate this with biopsy findings. More information will be extracted from the biopsy when there is close contact between clinician and pathologist. Discrepancies between the clinical and histological impressions should result in reevaluation of both types of data. For example, in a case where the biopsy shows a nonspecific picture suggesting great chronicity and prominence of regenerating clusters, the pathologist might offer the possibility that the neuropathy is genetically determined, and this may lead to a revealing reevaluation of the patient’s family history or greater emphasis placed on examination finding of foot deformity or scoliosis. Conversely, when the clinician suspects vasculitis or amyloidosis, the pathologist may examine additional sections with special stains if the initial assessment of the biopsy is unrevealing.
8.1 Clinical Approach to Peripheral Neuropathy
8.1.1 Clinical Questions
When assessing a patient with a suspected peripheral neuropathy, it is useful to consider several questions to help localize the problem and narrow the list of possible etiologies (Bromberg 2010). First, it is useful to ask if the clinical and examination features support a peripheral neuropathy. If present, what is the anatomical distribution of nerve involvement? What fiber types are involved? What is the temporal course? Is the primary pathological process demyelinating or axonal? This section will address these clinical questions in turn.
8.1.1.1 Is a Peripheral Neuropathy Present, and Is It the Cause of the Patient’s Symptoms?
It is not always easy to decide if a peripheral neuropathy is present and clinically significant, especially with predominantly sensory symptomatology or when additional nervous system pathology is present. Common motor and sensory symptoms can be due to many other peripheral or central nervous system causes. Of 267 consecutive biopsies from the St. Michael’s laboratory (1987–1993), 33 were found to be normal or insignificantly abnormal; a diagnosis other than peripheral neuropathy was ultimately made in most, including plexopathy, radiculopathy, myelopathy, neuromuscular junction disorder, or myopathy. Others report similar findings (Prineas 1970). Electrophysiological tests are extremely important in resolving this problem but are not 100 % sensitive (vide infra). Neurological examination is also helpful in excluding a central nervous system etiology. Since many neuropathies are distal and symmetric, muscle bulk in the hands and feet should be assessed. Foot deformities, such as hammer toes and pes cavus may be seen in chronic neuropathies. Hyporeflexia or areflexia in the anatomical distribution of symptoms should be present in most peripheral neuropathies. Sensory examination should be guided by the differential diagnosis derived from history, looking specifically for sensory loss in a pattern suggesting a lesion of an individual nerve, multiple nerves, a nerve root, or in a distal symmetrical (glove and stocking) distribution. Small fiber (pain, temperature) and large fiber (vibration, proprioception) modalities should be assessed.
8.1.1.2 What Is the Distribution of the Peripheral Nerve Disease?
History, physical examination, and electrophysiological testing clarify the spatial pattern of the patient’s peripheral nerve problem. A mononeuropathy affects one nerve only. A mononeuropathy multiplex involves several individual nerve trunks, including nerve roots or cranial nerves. A polyneuropathy is a generalized disorder of peripheral nerves, with clinical findings usually symmetrical and length dependent (more pronounced distally). Making this syndromic diagnosis is important, for it narrows the diagnostic possibilities considerably and directs further testing. One would not, for example, biopsy a sural nerve if there was no evidence of disease anywhere except for isolated radial or common peroneal nerve palsy. Electrophysiological tests are critical for detection of subclinical polyneuropathy or multifocal nerve disease.
The boundary between mononeuropathy multiplex and polyneuropathy is often unclear. As the number of individual nerves involved increases, deficits become confluent and the clinical picture may be similar to that of a distally predominant polyneuropathy (Waxman et al. 1976). Again, electrophysiological testing may reveal evidence that the abnormalities are asymmetric or that there is prominent proximal involvement, both favoring a confluent mononeuropathy multiplex (Vavra and Rubin 2011; Olney 1992).
8.1.1.3 What Is the Fiber Type Affected?
Most neuropathies impair both motor and sensory functions. Early, patients usually complain of distal sensory disturbances (paresthesias, numbness), as they are unlikely to notice distal intrinsic foot muscle weakness. In such cases, careful examination and electrophysiological testing are critical to clarify the fiber types involved. Clinically, it is important to determine if predominantly small or large sensory fibers are affected. Loss of pain and temperature sensation (small fiber) with relative sparing of joint position and vibration modalities (large fiber) is evidence of a small fiber neuropathy. This pattern is uncommon but extremely useful if found, for the differential diagnosis is limited (Table 7.7). More common and nonspecific are nonselective fiber loss or more prominent involvement of large fibers. Notably, deep tendon reflexes and routine electrophysiological testing do not assess small fiber function and thus may be entirely normal in this setting. Small fiber neuropathies often involve the autonomic nervous system, and testing of autonomic reflexes provides some information about unmyelinated fiber pathology.
Pure sensory or pure motor neuropathies have specific differential diagnostic implications (Tables 8.1 and 8.2). Neuropathies with predominant small fiber and/or autonomic involvement are listed in Table 8.3.
Table 8.1
Predominantly sensory neuropathies*
Inflammatory |
Inflammatory polyganglionopathy (IPG) not associated with malignancy |
Sjogren’s syndrome (can be associated with IPG) |
Predominantly sensory Guillain–Barre syndrome (unusual) |
Predominantly sensory CIDP (unusual) |
Vasculitic neuropathy (unusual) |
Sensory perineuritis |
Infection associated |
HIV distal predominantly sensory neuropathy (DSPN) |
Leprosy |
Lyme disease |
Metabolic |
Diabetes |
Hypothyroidism |
Uremia |
Liver disease (including primary biliary cirrhosis) |
Nutritional |
B12 deficiency |
Pyridoxine excess |
Thiamine deficiency (atypical cases) |
Vitamin E deficiency |
Strachan syndrome (Cuban neuropathy) |
Toxins |
Cisplatin |
Chloramphenicol |
Metronidazole, misonidazole |
Isoniazid, ethionamide |
Nitrous oxide |
L-tryptophan |
Thalidomide |
Ethylene oxide |
Chlorpyrifos (organophosphate insecticide) |
Neoplasia associated |
Paraneoplastic sensory ganglionopathy |
Paraprotein associated |
Infiltration with lymphoma/leukemia |
Genetically determined |
Associated with spinocerebellar degeneration, especially Friedreich’s ataxia |
Hereditary sensory and autonomic neuropathies (HSAN) |
Fabry disease |
Tangier disease |
Table 8.2
Predominantly motor neuropathy
Inflammatory/demyelinating |
GBS or CIDP with motor predominance (common) |
Multifocal motor neuropathy with conduction block |
Infection associated |
Diphtheria |
Metabolic |
Porphyria |
Hypoglycemia-associated neuropathy |
Toxic |
Lead, mercury |
Dapsone |
Organophosphate poisoning |
Neoplasm associated |
Lymphoma-associated motor neuropathy |
Paraprotein-associated motor neuropathy |
POEMS syndrome |
Genetically determined |
CMT-1 |
CMT-2 |
Table 8.3
Predominantly small fiber neuropathy
Inflammatory |
GBS |
Autoimmune autonomic ganglionopathy |
Infectious |
HIV associated |
Lepromatous leprosy |
Metabolic or systemic disease |
Diabetes (most common etiology) |
Amyloidosis |
Porphyria |
Sarcoidosis |
Alcohol |
Neoplasm associated |
Paraneoplastic neuropathy |
Genetically determined |
Hereditary sensory and autonomic neuropathies (HSAN) |
Fabry disease |
Tangier disease |
Amyloidosis (familial) |
8.1.1.4 Temporal Course
In neurological parlance, an acute process evolves over less than 2–4 weeks, a chronic process evolves over years, and a subacute process lies in between (usually months to a year or two). The distinction is important, since the differential diagnosis of acute neuropathy is considerably more limited (Table 8.4). In general, an acute presentation should make one think of Guillain–Barre syndrome (GBS) or vasculitis and more rarely infections, porphyria, or some toxins (e.g., arsenic). A relapsing course is often associated with inflammatory conditions such as chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) or vasculitis but can also occur with porphyria.
Table 8.4
Syndromic classification of neuropathy
Focal neuropathy/mononeuropathy |
Compression/trauma |
Diabetes |
Vasculitis |
Herpes zoster |
Neoplasm |
Radiation |
Leprosy |
Sarcoidosis |
Hypothyroidism, acromegaly, cachexia: predispose to mononeuropathies (e.g., median neuropathy at the wrist) |
Multifocal neuropathy |
Demyelinating |
Multiple compression |
CIDP |
GBS |
Multifocal motor neuropathy |
Hereditary neuropathy with pressure palsies (HNPP) |
POEMS syndrome |
Radiation plexopathy |
Tangier disease (some cases) |
Axonal |
Vasculitis |
Primary vasculitis: polyarteritis nodosa, granulomatosis with polyangiitis (Wegener’s), Churg–Strauss |
Secondary to connective tissue disease or systemic disease: rheumatoid arthritis, SLE, HIV, cryoglobulinemia (often associated with hepatitis C) |
Isolated PNS vasculitis |
Diabetes |
Sarcoidosis |
Leprosy |
Lyme disease |
Perineuritis |
Bacterial endocarditis |
Neoplastic nerve infiltration |
Hemorrhagic diathesis |
Primary nerve tumors (e.g., neurofibromatosis) |
Axonal polyneuropathy |
Acute |
Axonal GBS |
Porphyria |
Critical illness polyneuropathy |
Toxic exposures |
Misonidazole, nitrofurantoin |
Arsenic, thallium |
Alcohol/nutritional |
Acquired subacute/chronic |
Diabetes |
Toxic exposures (alcohol, drugs, industrial) |
Vasculitis |
Collagen diseases without vasculitis |
Nutritional defects (B12, B6, B1, vitamin E) |
Uremia |
Hypothyroidism |
HIV, HTLV-I |
Lyme disease |
Paraproteinemia |
Paraneoplastic |
Neoplastic infiltration |
Sarcoidosis |
Hypereosinophilic syndrome |
Perineuritis |
Genetically determined chronic
![]() Stay updated, free articles. Join our Telegram channel![]() Full access? Get Clinical Tree![]() ![]() ![]() |